Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Update

Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) was the target of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 14,600 shares, a decline of 57.4% from the October 31st total of 34,300 shares. Based on an average daily volume of 254,600 shares, the short-interest ratio is currently 0.1 days.

Chugai Pharmaceutical Trading Up 1.7 %

CHGCY opened at $22.00 on Friday. The business’s 50-day simple moving average is $23.21 and its 200-day simple moving average is $20.85. Chugai Pharmaceutical has a one year low of $14.52 and a one year high of $26.00.

Chugai Pharmaceutical Company Profile

Chugai Pharmaceutical Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company’s products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.